Institutional investors purchased a net $856.6 thousand shares of ENTA during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 31.26% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 779.4 Thousand shares of Enanta Pharmaceuticals In...
CONSONANCE CAPITAL MANAGEMENT LP Bought 281.8 Thousand shares of Enanta Pharmaceuticals In...